Milea Timbergen

179 17 . van Broekhoven DL, Grunhagenl DJ, van Dalen T, van Coevorden F, Bonenkamp HJ, Been LB, et al. Tailored Beta-catenin mutational approach in extra-abdominal sporadic desmoid tumor patients without therapeutic intervention. BMC Cancer. 2016;16(1):686. 18 . Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228-247. 19 . Murad MH, Sultan S, Haffar S, Bazerbachi F. Methodological quality and synthesis of case series and case reports. BMJ Evid Based Med. 2018;23(2):60-63. 20 . Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso-Coello P, et al. GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias). J Clin Epidemiol. 2011;64(4):407-415. 21 . Duazo-Cassin L, Le Guellec S, Lusque A, Chantalat E, Lae M, Terrier P, et al. Breast desmoid tumor management in France: toward a new strategy. Breast Cancer Res Treat. 2019;176(2):329-335. 22 . Salas S, Dufresne A, Bui B, Blay JY, Terrier P, Ranchere-Vince D, et al. Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation. J Clin Oncol. 2011;29(26):3553-3558. 23 . Roussin S, Mazouni C, Rimareix F, Honore C, Terrier P, Mir O, et al. Toward a new strategy in desmoid of the breast? Eur J Surg Oncol. 2015;41(4):571-576. 24 . Dalén BPM, Geijer M, Kvist H, Bergh PM, Gunterberg BUP. Clinical and imaging observations of desmoid tumors left without treatment. Acta Orthop Scand. 2006;77(6):932-937. 25 . Bertagnolli MM, Morgan JA, Fletcher CDM, Raut CP, Dileo P, Gill RR, et al. Multimodality treatment of mesenteric desmoid tumours. European Journal of Cancer. 2008;44(16):2404-2410. 26 . Nakayama T, Tsuboyama T, Toguchida J, Hosaka T, Nakamura T. Natural course of desmoid-type fibromatosis. Journal of Orthopaedic Science. 2008;13(1):51-55. 27 . Barbier O, Anract P, Pluot E, Larouserie F, Sailhan F, Babinet A, et al. Primary or recurring extra- abdominal desmoid fibromatosis: assessment of treatment by observation only. Orthop Traumatol Surg Res. 2010;96(8):884-889. 28 . Huang K, Wang CM, Chen JG, Du CY, Zhou Y, Shi YQ, et al. Prognostic factors influencing event-free survival and treatments in desmoid-type fibromatosis: Analysis from a large institution. American Journal of Surgery. 2014;207(6):847-854. 29 . Burtenshaw SM, Cannell AJ, McAlister ED, Siddique S, Kandel R, Blackstein ME, et al. Toward Observation as First-line Management in Abdominal Desmoid Tumors. Annals of Surgical Oncology. 2016;23(7):2212-2219. 30 . Park JS, Nakache YP, Katz J, Boutin RD, Steffner RJ, Monjazeb AM, et al. Conservative management of desmoid tumors is safe and effective. Journal of Surgical Research. 2016;205(1):115-120. 31 . Cassidy MR, Lefkowitz RA, Long N, Qin LX, Kirane A, Sbaity E, et al. Association of MRI T2 Signal Intensity With Desmoid Tumor Progression During Active Observation: A Retrospective Cohort Study. Ann Surg. 2018;271(4):748-755. 32 . van Broekhoven DLM, Verschoor AJ, van Dalen T, Grunhagen DJ, den Bakker MA, Gelderblom H, et al. Outcome of Nonsurgical Management of Extra-Abdominal, Trunk, and Abdominal Wall Desmoid- Type Fibromatosis: A Population-Based Study in the Netherlands. Sarcoma. 2018;2018:5982575. 33 . de Bruyns A, Li H, MacNeil A, Simmons C, Clarkson P, Goddard K, et al. Evolving Practice Patterns Over Two Decades (1993-2013) in the Management of Desmoid-type Fibromatosis in British Columbia. Clin Oncol (R Coll Radiol). 2019;32(3):e102-e110. 34 . Krieg AH, Wirth C, Lenze U, Kettelhack C, Coslovsky M, Baumhoer D, et al. Extra-abdominal desmoid tumours - further evidence for the watchful waiting policy. Swiss Med Wkly. 2019;149:w20107. 35 . Shen C, Wang C, Yan J, He T, Zhou X, Ma W, et al. Clinicopathological characteristics, treatment, and survival outcomes of retroperitoneal desmoid-type fibromatosis: A single-institution experience in China. Medicine (Baltimore). 2019;98(47):e18081. 36 . van Houdt WJ, Husson O, Patel A, Jones RL, Smith MJF, Miah AB, et al. Outcome of Primary Desmoid Tumors at All Anatomic Locations Initially Managed with Active Surveillance. Ann Surg Oncol. 2019;26(13):4699-4706. 6